Related Experiment Video
Updated: Jun 17, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Hormone replacement after gynaecological cancer
1Dept of Gynaecological Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
Maturitas
|December 19, 2009
Summary
Hormone replacement therapy (HRT) can effectively manage severe menopausal symptoms in gynecological cancer survivors. Current evidence suggests HRT is generally safe for most survivors, even those with hormone-sensitive cancers, improving quality of life.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
- Oncology Patient Care
Background:
- Gynecological cancer treatment often causes iatrogenic menopause, leading to intense symptoms.
- These symptoms significantly impact quality of life, affecting physical and psychological well-being.
- Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms.
Purpose of the Study:
- To evaluate the safety and efficacy of HRT in gynecological cancer survivors.
- To address concerns regarding HRT's potential to stimulate residual cancer or induce new hormone-dependent disease.
- To provide evidence-based information for informed patient decision-making regarding HRT.
Main Methods:
- Review of current scientific literature and evidence on HRT use in gynecological cancer patients.
- Analysis of the hormonal dependency of common gynecological malignancies.
- Assessment of HRT's impact on outcomes in patients treated for hormone-sensitive cancers.
Main Results:
- Most common gynecological cancers (cervix, ovary, vulva) are not estrogen-dependent.
- Evidence does not indicate adverse outcomes with HRT in patients treated for hormone-sensitive endometrial cancers.
- HRT is contraindicated only in a small subset of gynecological malignancies, such as low-grade endometrial stromal sarcomas.
Conclusions:
- HRT can be safely used by most gynecological cancer survivors to manage menopausal symptoms and improve quality of life.
- Unbiased patient information is crucial for informed decisions about HRT, as it rarely compromises survival.
- The benefits of HRT in managing debilitating symptoms often outweigh the minimal risks for most survivors.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...